MedTrace Logo

Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?

NCT03469596 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2018-03-22

No results posted yet for this study

Summary

Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up of these patients.It appears that clinical regression seen precociously is a predictive factor of survival without relapse. But there 's no study confirming that point.

This context takes us to evaluate if there is a predictive factor in MRI to final clinical result.

Conditions

  • Anal Carcinoma

Interventions

DIAGNOSTIC_TEST

MRI sequence

several MRI sequence before and after contrast product injection.

Sponsors & Collaborators

  • Fondation Hôpital Saint-Joseph

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2017-05-01
Completion
2017-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03469596 on ClinicalTrials.gov